Evidence map›Paper›PMID 33573353›Full record

ReviewBiomolecules2021

ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?

Kelly Féral, Manon Jaud, Céline Philippe, Doriana Di Bella, Stéphane Pyronnet, Kevin Rouault-Pierre, Laurent Mazzolini, Christian Touriol

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kelly FéralInserm UMR1037-Cancer Research Center of Toulouse, 2 avenue Hubert Curien, Oncopole entrée C, CS 53717, 31037 Toulouse, France.
Manon JaudInserm UMR1037-Cancer Research Center of Toulouse, 2 avenue Hubert Curien, Oncopole entrée C, CS 53717, 31037 Toulouse, France.
Céline PhilippeBarts Cancer Institute, Queen Mary University of London, London E1 4NS, UK.
Doriana Di BellaBarts Cancer Institute, Queen Mary University of London, London E1 4NS, UK.
Stéphane PyronnetInserm UMR1037-Cancer Research Center of Toulouse, 2 avenue Hubert Curien, Oncopole entrée C, CS 53717, 31037 Toulouse, France.ORCID 0000-0002-9562-5112
Kevin Rouault-PierreBarts Cancer Institute, Queen Mary University of London, London E1 4NS, UK.ORCID 0000-0001-7671-7364
Laurent MazzoliniInserm UMR1037-Cancer Research Center of Toulouse, 2 avenue Hubert Curien, Oncopole entrée C, CS 53717, 31037 Toulouse, France.ORCID 0000-0002-5974-1239
Christian TouriolInserm UMR1037-Cancer Research Center of Toulouse, 2 avenue Hubert Curien, Oncopole entrée C, CS 53717, 31037 Toulouse, France.ORCID 0000-0003-1219-4693
Université Toulouse III - Paul Sabatier · FRQueen Mary University of London · GBCentre National de la Recherche Scientifique · FR

Funding

Academy of Medical Sciences SBF0041099Association Laurette Fugain ALF2018/03Kay Kendall Leukaemia Fund KKL1149
6 · The paper itself

Abstract

The unfolded protein response (UPR) is an evolutionarily conserved adaptive signaling pathway triggered by a stress of the endoplasmic reticulum (ER) lumen compartment, which is initiated by the accumulation of unfolded proteins. This response, mediated by three sensors-Inositol Requiring Enzyme 1 (IRE1), Activating Transcription Factor 6 (ATF6), and Protein Kinase RNA-Like Endoplasmic Reticulum Kinase (PERK)-allows restoring protein homeostasis and maintaining cell survival. UPR represents a major cytoprotective signaling network for cancer cells, which frequently experience disturbed proteostasis owing to their rapid proliferation in an usually unfavorable microenvironment. Increased basal UPR also participates in the resistance of tumor cells against chemotherapy. UPR activation also occurs during hematopoiesis, and growing evidence supports the critical cytoprotective role played by ER stress in the emergence and proliferation of leukemic cells. In case of severe or prolonged stress, pro-survival UPR may however evolve into a cell death program called terminal UPR. Interestingly, a large number of studies have revealed that the induction of proapoptotic UPR can also strongly contribute to the sensitization of leukemic cells to chemotherapy. Here, we review the current knowledge on the consequences of the deregulation of UPR signaling in leukemias and their implications for the treatment of these diseases.

Indexed as

Gene Expression Regulation, LeukemicSignal TransductionUnfolded Protein ResponseActivating Transcription Factor 6AnimalsApoptosisAutophagyCalciumCell SurvivalDNA, MitochondrialeIF-2 KinaseEndoplasmic ReticulumEndoplasmic Reticulum StressEndoribonucleasesHomeostasisHumansActivating Transcription Factor 6ATF6 protein, humanCalciumDNA, MitochondrialeIF-2 KinaseEndoribonucleasesERN1 protein, humanIonsLipidsProtein Serine-Threonine KinasesALLAMLCLLCMLendoplasmic reticulum stressleukemiaunfolded protein response (UPR)

Identifiers

PMID33573353
PMCPMC7911881
OpenAlexW3126594506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.